AgeneBio founder Michela Gallagher to speak on emerging #Alzheimers therapies at @ASENT_Org 2018 Annual Meeting bit.ly/2BX7dLZ
English
AgeneBio
47 posts
AgeneBio
@AgeneBio
AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.
Baltimore, MD Katılım Ekim 2014
38 Takip Edilen127 Takipçiler
AgeneBio founder Michela Gallagher to speak at 2018 @NIH #Alzheimers Research Summit on March 2 bit.ly/2BWjIY6 #ADSummit18
English
AgeneBio receives NIH grant to initiate Phase 3 HOPE4MCI trial to treat MCI due to #Alzheimers disease bit.ly/2f7DkMe
English
AgeneBio receives up to $10M in NIH funding to advance program for mild cognitive impairment due to #alzheimers bit.ly/2xZqmrl
English
Thanks 2 @TheADDF 4 another grant--will fund GABA-A drug-discovery program to delay onset of #Alzheimers dementia bit.ly/2ty3l0u
English
Our new corporate presentation is loaded on agenebio.com/investor-relat… #Alzheimers
English
CEO Jerry McLaughlin presenting today at 3:35pm in NYC @ Neuroscience BioPartnering & Investment Forum bit.ly/218rx0P #Alzheimers
English
Looking fwd 2 tomorrow's Neuroscience BioPartnering & Investment Forum CEO Jerry McLaughlin to present bit.ly/218rx0P #Alzheimers
English
CEO Jerry McLaughlin 2 present @ Neuroscience BioPartnering & Investment Forum bit.ly/218rx0P #Alzheimer #Phase3 #aMCI
English
Looking forward 2 @IAmBiotech CEO & Investor Conf our CEO on tap Feb 8 10:15am NYC bit.ly/1SVPPcL #alzheimers #phase3
English
AgeneBio CEO Jerry McLaughlin to present at @IAmBiotech CEO & Investor Conf Feb 8 10:15am NYC bit.ly/1SVPPcL #alzheimers #phase3
English
We've shared a new corporate deck on agenebio.com and on SlideShare slideshare.net/AgeneBio #Alzheimers
English
AgeneBio retweetledi
Check out the new @AgeneBio Phase 3 #clinicaltrial website for prevention/delay of #Alzheimers/#dementia: HOPE4MCI.org
English
AgeneBio launches new HOPE4MCI.org Phase 3 clinical website for prevention/delay of Alzheimer’s dementia #Alzheimers
English
We've shared a new corporate deck on our agenebio.com and on SlideShare slideshare.net/AgeneBio #Alzheimers
English
We welcome the distinguished Dr. Richard Mohs as our VP, Clinical Development for #Alzheimer's Phase3 HOPE4MCI trial
bit.ly/1IRz8GJ
English
.@alzforum reviews our own Dr. Gallagher's CTAD session on new #Alzheimers Phase 3 #clinicaltrials
bit.ly/21fGUWm
English
AgeneBio CEO Jerry McLaughlin to present @ Future of Innovation in Medicine Conference @gatesfoundation
bit.ly/1N6oGvI #Alzheimers
English
AgeneBio to Present as a Top Project to Watch: Most Licensable Products in Neuroscience @ TAP Conference bit.ly/1MDV50W #Alzheimers
English